Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.12%ABBV-2.40%1398.HK-1.47%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.04%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.73%1288.HK-1.97%MS-1.78%NFLX-0.21%CADCHF+0.60%GBPCHF+0.51%GBPTRY+0.41%NZDCHF+0.40%AUDCHF+0.40%USDCAD-0.39%EURCAD-0.33%CADJPY+0.33%GBPHKD+0.32%GBPUSD+0.30%GBPMXN-0.28%USDTRY+0.27%EURCHF+0.27%CHFJPY-0.25%NZDSGD+0.24%AUDSGD+0.24%GBPJPY+0.24%USDNOK-0.24%NZDUSD+0.22%EURGBP-0.21%USDCHF+0.20%NZDCAD-0.20%AUDCAD-0.19%AUDUSD+0.19%NZDMXN+0.19%GBPSGD+0.19%USDZAR-0.18%NOKJPY+0.18%USDILS+0.16%USDSEK-0.16%USDPLN-0.16%EURSGD+0.16%NZDJPY+0.15%CHFSGD+0.15%CHFNOK-0.14%AUDJPY+0.14%EURNOK-0.13%GBPAUD+0.12%SGDJPY-0.11%EURNZD-0.11%EURHKD+0.11%USDDKK-0.10%EURAUD-0.10%PLNJPY+0.10%EURCNH+0.09%AUDDKK+0.08%GBPCAD-0.08%GBPNZD+0.07%EURUSD+0.07%CHFSEK-0.07%EURZAR-0.06%EURSEK-0.06%EURPLN-0.05%USDSGD+0.05%USDJPY-0.05%GBPZAR-0.05%AUDNOK-0.05%USDTHB+0.04%USDCOP-0.04%EURJPY+0.03%USDCNH-0.02%EURCZK+0.01%USDHKD+0.01%USDMXN0.00%AUDNZD0.00%EURDKK0.00%COTTON+0.74%HG1+0.66%XNGUSD+0.41%S1+0.35%W1-0.28%UKOIL-0.16%USOIL-0.11%XAUUSD+0.08%GAUUSD+0.08%XPTUSD-0.07%XAGUSD+0.07%GAGUSD+0.07%BTCUSD+2.55%ETHUSD+17.67%USDTUSD0.00%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.83%ZECUSDT+8.69%DOGEUSD+14.12%XMRUSDT+5.35%LINKUSD+13.42%XLMUSD+0.25%BCHUSDT+5.89%UNIUSD+8.15%LTCUSD+9.66%SUIUSD+3.70%HBARUSDT+0.66%TONUSD+26.15%TAOUSDT+3.71%AAVEUSD+3.45%DOTUSDT-0.03%ICPUSDT+0.40%ONDOUSDT+0.74%WLDUSDT-0.60%ARBUSDT+6.97%JUPUSDT+0.92%ATOMUSDT+1.46%INJUSDT+13.09%STXUSDT+7.49%FETUSDT+1.71%TIAUSDT+8.81%PYTHUSDT+2.44%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+21.23%GRTUSDT+4.23%IOTAUSDT+1.20%WIFUSDT+2.21%AXSUSDT-1.23%POLUSDT+3.23%FARTCOINUSDT+1.40%EOSUSDT+0.71%DYDXUSDT+4.53%GALAUSDT-1.41%ORDIUSDT+0.18%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.12%ABBV-2.40%1398.HK-1.47%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.04%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.73%1288.HK-1.97%MS-1.78%NFLX-0.21%CADCHF+0.60%GBPCHF+0.51%GBPTRY+0.41%NZDCHF+0.40%AUDCHF+0.40%USDCAD-0.39%EURCAD-0.33%CADJPY+0.33%GBPHKD+0.32%GBPUSD+0.30%GBPMXN-0.28%USDTRY+0.27%EURCHF+0.27%CHFJPY-0.25%NZDSGD+0.24%AUDSGD+0.24%GBPJPY+0.24%USDNOK-0.24%NZDUSD+0.22%EURGBP-0.21%USDCHF+0.20%NZDCAD-0.20%AUDCAD-0.19%AUDUSD+0.19%NZDMXN+0.19%GBPSGD+0.19%USDZAR-0.18%NOKJPY+0.18%USDILS+0.16%USDSEK-0.16%USDPLN-0.16%EURSGD+0.16%NZDJPY+0.15%CHFSGD+0.15%CHFNOK-0.14%AUDJPY+0.14%EURNOK-0.13%GBPAUD+0.12%SGDJPY-0.11%EURNZD-0.11%EURHKD+0.11%USDDKK-0.10%EURAUD-0.10%PLNJPY+0.10%EURCNH+0.09%AUDDKK+0.08%GBPCAD-0.08%GBPNZD+0.07%EURUSD+0.07%CHFSEK-0.07%EURZAR-0.06%EURSEK-0.06%EURPLN-0.05%USDSGD+0.05%USDJPY-0.05%GBPZAR-0.05%AUDNOK-0.05%USDTHB+0.04%USDCOP-0.04%EURJPY+0.03%USDCNH-0.02%EURCZK+0.01%USDHKD+0.01%USDMXN0.00%AUDNZD0.00%EURDKK0.00%COTTON+0.74%HG1+0.66%XNGUSD+0.41%S1+0.35%W1-0.28%UKOIL-0.16%USOIL-0.11%XAUUSD+0.08%GAUUSD+0.08%XPTUSD-0.07%XAGUSD+0.07%GAGUSD+0.07%BTCUSD+2.55%ETHUSD+17.67%USDTUSD0.00%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.83%ZECUSDT+8.69%DOGEUSD+14.12%XMRUSDT+5.35%LINKUSD+13.42%XLMUSD+0.25%BCHUSDT+5.89%UNIUSD+8.15%LTCUSD+9.66%SUIUSD+3.70%HBARUSDT+0.66%TONUSD+26.15%TAOUSDT+3.71%AAVEUSD+3.45%DOTUSDT-0.03%ICPUSDT+0.40%ONDOUSDT+0.74%WLDUSDT-0.60%ARBUSDT+6.97%JUPUSDT+0.92%ATOMUSDT+1.46%INJUSDT+13.09%STXUSDT+7.49%FETUSDT+1.71%TIAUSDT+8.81%PYTHUSDT+2.44%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+21.23%GRTUSDT+4.23%IOTAUSDT+1.20%WIFUSDT+2.21%AXSUSDT-1.23%POLUSDT+3.23%FARTCOINUSDT+1.40%EOSUSDT+0.71%DYDXUSDT+4.53%GALAUSDT-1.41%ORDIUSDT+0.18%RONINUSDT-3.42%NOTUSDT+1.21%
CR

Cronos Group Inc. (CRON)

NASDAQ • Healthcare

$3.2
-$0 (-0.3%)
Market closed

October 13, 2026 at 20:00 UTC

Open$3.21
Day Range$3.18 - $3.25
Avg. Volume (3M)858.5K
Market Cap$1.1B
P/E Ratio17.8
52 Week Range
$2.28$3.61
Next EarningsIn 22 daysNov 5, 2026

Interactive Chart

03:46:10 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$53M100%
Gross Profitminus cost of goods$28.4M54%
Operating Incomeminus R&D and overhead$7.6M14%
Net Incomeminus taxes and the rest$32M61%

In plain terms: out of every $100 in revenue, Cronos Group Inc. keeps $61 as net profit.

Fundamentals & Financials

Revenue (TTM)
$225.2M
Net Income (TTM)
$69.7M
EPS (TTM)
$0.18
ROA (TTM)
5.91%
Current Ratio
16.18
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-147.0%Q1 2026$0
0.0%Q2 2026$0.01
+800.0%Q3 2026$0.09
Next

Nov 5

in 22 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +800.0%

Cronos Group's revenue topped consensus in the second fiscal quarter of 2026, with results reported on Aug. 6 showing about $70.6 million in revenue versus roughly $43.0 million expected, a 64.4% beat, and revenue was up 111% from $33.5 million a year ago. Gross profit came in at about $28.5 million, with gross margin near 40%, while operating cash flow was about $18.8 million. Consensus for the next period calls for EPS of $0.01 on revenue of $55.1 million.

Next report — what to expect

Cronos Group Inc (CRON) reports on November 5, 2026. For the upcoming quarter, consensus calls for EPS of $0.03 on revenue of $49.5 million; as trailing context, revenue grew +58.4% year over year last quarter. Cronos has beaten EPS in 5 of its 8 most recent quarters.

View full earnings history

About Cronos Group Inc.

Cronos Group Inc. is a NASDAQ-listed healthcare company that develops cannabinoid products for therapeutic and recreational use, spanning cannabis cultivation, production, and commercialization. In FY2025, the company recorded $193.4 million in revenue. Its portfolio ranges from hemp-derived wellness and beauty products to dried cannabis formats, oils, and extracts sold under consumer brands.

Name
Cronos Group Inc.
CEO
Michael Ryan Gorenstein
Website
www.thecronosgroup.com
Industry
Healthcare
Year Founded
2012
Employees
610

Today's Snapshot

AI-generated

CRON closed slightly lower at 3.20, while its sector was weaker. Trading was lighter than usual, with volume about half of its usual level. Cronos Group revived its popular green-apple cannabis product.

Trading Volume

Below 10d avg (931.9K)

513.5K

vs S&P 500 Today

Moderate Underperformance

-0.29%

Updated: October 13, 2026 at 20:28 UTC

Technical Indicators

3 Buy2 Neutral3 Sell
CRON is trading at 3.20 and shows a sell bias driven by weak momentum and negative volume patterns. The CCI is firmly negative and the MACD is marginally negative, while short- and medium-term moving averages are under pressure even though the longer-term 200-day level remains below price. Trend strength is limited with an ADX in the mid-teens, and volatility is moderate with an ATR near 2.7%. On-balance volume is negative, suggesting distribution. Technical takeaway: Sell bias reflecting weak momentum and negative volume, with the trend lacking conviction.
All signals
  • EMA (5 indicators)$2.89 - $3.26
    Buy
  • RSI (14)44.69
    Neutral
  • Stochastic %K (14, 3, 3)20.43
    Neutral
  • MACD Level (12, 26)-0.01
    Sell

Peers & Related Assets

NRIXNurix Therapeutics, Inc.
$22.13-0.1%
XNCRXencor, Inc.
$23.52-6.1%
PCRXPacira BioSciences, Inc.
$36.31-0.1%
RAPPRapport Therapeutics, Inc. Common Stock
$28.99-3.9%
AMPHAmphastar Pharmaceuticals, Inc.
$26.05-2.6%
IRMDIRadimed Corporation
$89.65+0.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.